[AMRX] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
05-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 64.70%
YoY- 92.30%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 498,533 397,328 378,283 404,642 446,120 497,528 476,487 3.05%
PBT 13,344 -57,111 26,276 -56,227 -133,180 -14,806 22,574 -29.54%
Tax -108,173 7,792 389,668 -5,701 -8,428 5,524 5,109 -
NP 115,067 -32,128 -265,006 -16,902 -47,881 -8,768 6,952 548.36%
Tax Rate 810.65% - -1,482.98% - - - -22.63% -
Total Cost 383,466 429,456 643,289 421,544 494,001 506,296 469,535 -12.61%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 23.08 -8.09 -70.05 -4.18 -10.73 -1.76 1.46 528.81%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS 0.78 -0.23 -2.03 -0.13 -0.37 -0.07 0.05 523.29%
EPS Diluted 0.78 -0.23 -2.03 -0.13 -0.37 -0.07 0.05 523.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.